Chimeric Therapeutics Limited (CHMMF)
OTCMKTS · Delayed Price · Currency is USD
0.0010
-0.0290 (-96.67%)
At close: Sep 6, 2024
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of $6.41 million as of September 5, 2025. Its market cap has decreased by -41.70% in one year.
Market Cap
6.41M
Enterprise Value
2.63M
Revenue
8.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 74.92M to 6.41M, a decrease of -91.45%. That is a compound annual growth rate of -41.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 4.24M | -37.92% |
| Dec 31, 2024 | 6.82M | -60.60% |
| Dec 29, 2023 | 17.32M | -27.14% |
| Dec 30, 2022 | 23.77M | -62.54% |
| Dec 31, 2021 | 63.45M | -15.32% |
| Jan 18, 2021 | 74.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 891.61M |
| Elite Pharmaceuticals | 751.15M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 631.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 394.86M |
| American Oncology Network | 353.52M |